Surprisingly, genes that are most frequently mutated in AML, in particular FLT3 and NPM1, as well as some mutated genes reported previously, such as EZH2, KIT, and SF3B1, were not mutated in our study group [11,13]. This evidence concerns the gene EZH2 and acute myeloid leukemia.